← FDA DRUG APPROVALS

FDA ANDA · ANDA070965

CLONIDINE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA070965
TYPE
ANDA
ORIGINAL APPROVAL
1986-07-01
LATEST ACTION
1999-09-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CLONIDINE HYDROCHLORIDEDiscontinued
CLONIDINE HYDROCHLORIDE 0.1MG · TABLET · ORAL

Approval history

1999-09-07Manufacturing (CMC) · Supplement 18AP
1997-01-31Labeling · Supplement 16AP
1991-05-31Manufacturing (CMC) · Supplement 13AP
1991-05-15Labeling · Supplement 15AP
1991-01-28Manufacturing (CMC) · Supplement 14AP
1990-06-29Manufacturing (CMC) · Supplement 12AP
1988-04-07Labeling · Supplement 11AP
1988-03-25Manufacturing (CMC) · Supplement 9AP
1987-12-09Manufacturing (CMC) · Supplement 8AP
1987-05-15Manufacturing (CMC) · Supplement 4AP
1986-11-12Manufacturing (CMC) · Supplement 3AP
1986-11-12Manufacturing (CMC) · Supplement 1AP
1986-07-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →